288 related articles for article (PubMed ID: 20723213)
1. Leptin as a critical regulator of hepatocellular carcinoma development through modulation of human telomerase reverse transcriptase.
Stefanou N; Papanikolaou V; Furukawa Y; Nakamura Y; Tsezou A
BMC Cancer; 2010 Aug; 10():442. PubMed ID: 20723213
[TBL] [Abstract][Full Text] [Related]
2. Telomerase activity in human hepatocellular carcinoma: parallel correlation with human telomerase reverse transcriptase (hTERT) mRNA isoform expression but not with cell cycle modulators or c-Myc expression.
Chen CJ; Tsai NM; Liu YC; Ho LI; Hsieh HF; Yen CY; Harn HJ
Eur J Surg Oncol; 2002 Apr; 28(3):225-34. PubMed ID: 11944954
[TBL] [Abstract][Full Text] [Related]
3. Modulation of human telomerase reverse transcriptase in hepatocellular carcinoma.
Chen CJ; Kyo S; Liu YC; Cheng YL; Hsieh CB; Chan DC; Yu JC; Harn HJ
World J Gastroenterol; 2004 Mar; 10(5):638-42. PubMed ID: 14991929
[TBL] [Abstract][Full Text] [Related]
4. PPARgamma ligands inhibit telomerase activity and hTERT expression through modulation of the Myc/Mad/Max network in colon cancer cells.
Toaldo C; Pizzimenti S; Cerbone A; Pettazzoni P; Menegatti E; Daniela B; Minelli R; Giglioni B; Dianzani MU; Ferretti C; Barrera G
J Cell Mol Med; 2010 Jun; 14(6A):1347-57. PubMed ID: 19912441
[TBL] [Abstract][Full Text] [Related]
5. Cellular distribution of telomerase reverse transcriptase in human hepatocellular carcinoma.
Onishi T; Nouso K; Higashi T; Toshikuni N; Nakatsukasa H; Kobayashi Y; Uemura M; Yumoto E; Fujiwara K; Sato S; Nakamura S; Yokoyama J; Hanafusa T; Shiratori Y
J Gastroenterol Hepatol; 2003 Oct; 18(10):1168-74. PubMed ID: 12974904
[TBL] [Abstract][Full Text] [Related]
6. Butylidenephthalide suppresses human telomerase reverse transcriptase (TERT) in human glioblastomas.
Lin PC; Lin SZ; Chen YL; Chang JS; Ho LI; Liu PY; Chang LF; Harn YC; Chen SP; Sun LY; Huang PC; Chein JT; Tsai CH; Chou CW; Harn HJ; Chiou TW
Ann Surg Oncol; 2011 Nov; 18(12):3514-27. PubMed ID: 21553143
[TBL] [Abstract][Full Text] [Related]
7. Telomerase reverse transcriptase gene amplification in hepatocellular carcinoma.
Takuma Y; Nouso K; Kobayashi Y; Nakamura S; Tanaka H; Matsumoto E; Fujikawa T; Suzuki M; Hanafusa T; Shiratori Y
J Gastroenterol Hepatol; 2004 Nov; 19(11):1300-4. PubMed ID: 15482538
[TBL] [Abstract][Full Text] [Related]
8. Real-time quantification of human telomerase reverse transcriptase mRNA in liver tissues from patients with hepatocellular cancer and chronic viral hepatitis.
Satra M; Gatselis N; Iliopoulos D; Zacharoulis D; Dalekos GN; Tsezou A
J Viral Hepat; 2007 Jan; 14(1):41-7. PubMed ID: 17212643
[TBL] [Abstract][Full Text] [Related]
9. Reptin is required for the transcription of telomerase reverse transcriptase and over-expressed in gastric cancer.
Li W; Zeng J; Li Q; Zhao L; Liu T; Björkholm M; Jia J; Xu D
Mol Cancer; 2010 May; 9():132. PubMed ID: 20509972
[TBL] [Abstract][Full Text] [Related]
10. Hepatitis B virus protein preS2 potentially promotes HCC development via its transcriptional activation of hTERT.
Luan F; Liu H; Gao L; Liu J; Sun Z; Ju Y; Hou N; Guo C; Liang X; Zhang L; Sun W; Ma C
Gut; 2009 Nov; 58(11):1528-37. PubMed ID: 19651630
[TBL] [Abstract][Full Text] [Related]
11. Suppression of BRD4 inhibits human hepatocellular carcinoma by repressing MYC and enhancing BIM expression.
Li GQ; Guo WZ; Zhang Y; Seng JJ; Zhang HP; Ma XX; Zhang G; Li J; Yan B; Tang HW; Li SS; Wang LD; Zhang SJ
Oncotarget; 2016 Jan; 7(3):2462-74. PubMed ID: 26575167
[TBL] [Abstract][Full Text] [Related]
12. Telomerase reverse transcriptase mRNA expression and telomerase activity in hepatocellular carcinoma.
Nagao K; Tomimatsu M; Endo H; Hisatomi H; Hikiji K
J Gastroenterol; 1999 Feb; 34(1):83-7. PubMed ID: 10204615
[TBL] [Abstract][Full Text] [Related]
13. Quantitative assessment of hTERT mRNA expression in dysplastic nodules of HBV-related hepatocarcinogenesis.
Oh BK; Kim YJ; Park YN; Choi J; Kim KS; Park C
Am J Gastroenterol; 2006 Apr; 101(4):831-8. PubMed ID: 16494581
[TBL] [Abstract][Full Text] [Related]
14. RFX-1-dependent activation of SHP-1 inhibits STAT3 signaling in hepatocellular carcinoma cells.
Su JC; Chiang HC; Tseng PH; Tai WT; Hsu CY; Li YS; Huang JW; Ko CH; Lin MW; Chu PY; Liu CY; Chen KF; Shiau CW
Carcinogenesis; 2014 Dec; 35(12):2807-14. PubMed ID: 25322871
[TBL] [Abstract][Full Text] [Related]
15. The involvement of HER2 and p53 status in the regulation of telomerase in irradiated breast cancer cells.
Papanikolaou V; Iliopoulos D; Dimou I; Dubos S; Tsougos I; Theodorou K; Kitsiou-Tzeli S; Tsezou A
Int J Oncol; 2009 Nov; 35(5):1141-9. PubMed ID: 19787269
[TBL] [Abstract][Full Text] [Related]
16. Epigenetic regulation of hTERT promoter in hepatocellular carcinomas.
Iliopoulos D; Satra M; Drakaki A; Poultsides GA; Tsezou A
Int J Oncol; 2009 Feb; 34(2):391-9. PubMed ID: 19148473
[TBL] [Abstract][Full Text] [Related]
17. Telomerase activity, telomere length and human telomerase reverse transcriptase expression in hepatocellular carcinoma is independent of hepatitis virus status.
Saini N; Srinivasan R; Chawla Y; Sharma S; Chakraborti A; Rajwanshi A
Liver Int; 2009 Sep; 29(8):1162-70. PubMed ID: 19627485
[TBL] [Abstract][Full Text] [Related]
18. CSIG promotes hepatocellular carcinoma proliferation by activating c-MYC expression.
Cheng Q; Yuan F; Lu F; Zhang B; Chen T; Chen X; Cheng Y; Li N; Ma L; Tong T
Oncotarget; 2015 Mar; 6(7):4733-44. PubMed ID: 25749381
[TBL] [Abstract][Full Text] [Related]
19. Butein suppresses c-Myc-dependent transcription and Akt-dependent phosphorylation of hTERT in human leukemia cells.
Moon DO; Kim MO; Lee JD; Choi YH; Kim GY
Cancer Lett; 2009 Dec; 286(2):172-9. PubMed ID: 19560862
[TBL] [Abstract][Full Text] [Related]
20. PTEN and hTERT gene expression and the correlation with human hepatocellular carcinoma.
Zhou X; Zhu H; Lu J
Pathol Res Pract; 2015 Apr; 211(4):316-9. PubMed ID: 25613699
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
